pharma · Locally advanced or metastatic urothelial cancer · Nectin-4 Expressing Advanced Malignancies. · BCYC
BICYCLE THERAPEUTICS
BICYCLE THERAPEUTICS is a pharma organization headquartered in Cambridge, GB. It trades on NYSE under ticker BCYC. Primary therapeutic focus areas include Locally advanced or metastatic urothelial cancer, Nectin-4 Expres
Cambridge, GB HQ
2009 Founded
282 Employees
Public company Type
BCYC · NYSE Ticker
Company details
- Status
- Public
- HQ
- Cambridge, GB
- Founded
- 2009
- Employees
- 282
- Programs
- 8
- Drugs
- 15
- Patents
- 57
buprenorphine/naloxone
Approved · small molecule · Opioid Use Disorder
buprenorphine/naloxone for Opioid Use Disorder is a Approved program (small_molecule) at BICYCLE THERAPEUTICS with 1 ClinicalTrials.gov record(s).
Internal code Bicycle-005
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- BICYCLE THERAPEUTICS
- Phase
- Approved
- Modality
- small_molecule
- Indication
- Opioid Use Disorder
- Status
- terminated
- Trials
- 1